Find and Pitch Jounalists, Get Your Story Covered

Tags: career leadership nurses nursing succession

	Profile	Recent Articles on Subject
1	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	APhA 2025: Building Pharmacy's Future With Mentorship, Advocacy, and Professional Development - 8 days ago
2	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology - 8 days ago With uncertainty roiling Big Pharma, execs are placing lower-risk bets - about 2 months ago How Astellas juggles the moving parts of cancer precision medicine development - 4 months ago How Alexion markets a rare disease drug by ‘starting with the end in mind’ - 4 months ago How AZ’s respiratory wins are ramping up for a bigger prize in COPD - 5 months ago 2024 PharmaVoice 100s: Biotech Pathfinders - 5 months ago Top pharma and biotech conferences 2025 - 6 months ago A biotech dousing ‘fires’ in the brain that plagued a bestselling author - 8 months ago A new biotech tackling IBD joins a race against Lilly and Gilead for a promising pill - 9 months ago AstraZeneca’s $80B sales goal by 2030 reflects industry’s penchant for long-term bets - 11 months ago Ex-Novartis exec sets out to create ‘Apple of AI’ - about 1 year ago Big Pharma players Amgen, Roche and Pfizer seek to follow in Novo and Lilly’s weight loss footsteps - about 1 year ago How to make 2024 a banner year for biopharma, despite the headwinds - about 1 year ago Real Chemistry’s CEO on biopharma’s outlook in 2024 - over 1 year ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Pharma’s forecast for 2025: Sowing seeds of a rebound - 2 months ago 3 closely watched drugs that failed in the clinic - 4 months ago 2024 PharmaVoice 100s: Trailblazers - 6 months ago 2024 PharmaVoice 100s: Standout Leaders - 6 months ago Amylyx’s CEOs on their ALS setback and quest to revamp the pipeline - 9 months ago Up-and-comers look for an edge in the bustling ADC field - 9 months ago Behind a big-name rare disease biotech, an exec draws from personal experience - about 1 year ago Astellas’ science chief on the leap into new technologies - about 1 year ago Five years after closing the Shire deal, Takeda is ready to harvest from its latest reinvention - about 1 year ago 3 standout digital innovations in pharma this year - over 1 year ago PharmaVoice 100s: Entrepreneurs - over 1 year ago
4	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Key Insights From ASH and SABCS Showcase Advancements for the Field of Oncology Pharmacy - 3 months ago
5	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - 5 months ago STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more - 7 months ago STAT+: Pharmalittle: We’re reading about an Amgen obesity drug, a Senate bill on shortages, and more - 11 months ago STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more - 12 months ago STAT+: Pharmalittle: We’re reading about a GLP-1 side effect, U.K. clinical trial transparency, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about BIO cutting ties with WuXi, EU pharma rules, and more - about 1 year ago STAT+: Major generic maker Aurobindo cuts production at a key plant amid concerns over shortages - about 1 year ago STAT+: Pharmalittle: We’re reading about drug price hikes, Bayer strategic moves, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about a GSK deal, a probe into inhaler prices, and more - about 1 year ago STAT+: Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud - over 1 year ago STAT+: Pharmalittle: White House takes aim at pharma patents to lower drug prices; Sanofi CEO defends reducing earnings forecast - over 1 year ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - over 1 year ago STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill - over 1 year ago STAT+: Pharmalittle: Novo Nordisk sees “significantly” more Wegovy in the U.S. next year; U.S. pharma layoffs skyrocket - over 1 year ago STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer - over 1 year ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - over 1 year ago STAT+: Pharmalittle: China arrests an Astellas exec accused of spying; weight-loss drugs are being tested in children - over 1 year ago STAT+: Pharmalittle: Weight-loss drugs fuel boom for firms that fill syringes; employers that cover obesity drug may double in 2024 - over 1 year ago STAT+: Pharmalittle: Novo faces patent challenge on Wegovy and Ozempic; Senate panel moves to address drug shortages - over 1 year ago STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback - over 1 year ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Novo Nordisk Commits $285M to Ascendis to Kick Off Alliance on Longer-Acting GLP-1 Drugs - 5 months ago Aiming to Outdo Rivals in Severe Asthma, Upstream Bio Upsizes IPO to $225M - 6 months ago Ascendis Pharma Lands Long-Awaited FDA Drug Approval in Rare Hormone Deficiency - 8 months ago
7	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Pfizer’s quest for market share in the ‘high stakes battleground’ of oral GLP-1s - 5 months ago 2024 PharmaVoice 100s: Tech and AI Wizards - 5 months ago Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies - 11 months ago
8	PT Staff Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Pharmacist Spotlight: Anjeza Fero, PharmD, RPh - 7 months ago Pharmacist Spotlight: Cassandra Esperant, PharmD, AAHIVP - 9 months ago Condition Watch, June 2024 - 9 months ago June 2024 Products Column - 10 months ago Pharmacist Spotlight: Amina Abubakar, PharmD, AAHIVP - 10 months ago
9	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Dr Andriy Krendyukov - 11 months ago Marina Passarell - about 1 year ago David Lawrence - about 1 year ago
10	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	AstraZeneca Caps Inhaled Respiratory Portfolio at $35 For Eligible Patients With Asthma, COPD - about 1 year ago

Journalists covering Aspire Pharma